The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cell-Free DNA (cf-DNA) Testing-Global Market Insights and Sales Trends 2024
Synopsis
The global Cell-Free DNA (cf-DNA) Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell-Free DNA (cf-DNA) Testing in various end use industries. The expanding demands from the Oncology, Gynecology and Transplantation,, are propelling Cell-Free DNA (cf-DNA) Testing market. Donor-derived, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulating segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell-Free DNA (cf-DNA) Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell-Free DNA (cf-DNA) Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell-Free DNA (cf-DNA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell-Free DNA (cf-DNA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell-Free DNA (cf-DNA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell-Free DNA (cf-DNA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell-Free DNA (cf-DNA) Testing covered in this report include Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited and Natera, etc.
The global Cell-Free DNA (cf-DNA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Global Cell-Free DNA (cf-DNA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell-Free DNA (cf-DNA) Testing market, Segment by Type:
Donor-derived
Circulating
Cell-free
Global Cell-Free DNA (cf-DNA) Testing market, by Application
Oncology
Gynecology
Transplantation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell-Free DNA (cf-DNA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cell-Free DNA (cf-DNA) Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cell-Free DNA (cf-DNA) Testing in various end use industries. The expanding demands from the Oncology, Gynecology and Transplantation,, are propelling Cell-Free DNA (cf-DNA) Testing market. Donor-derived, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Circulating segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cell-Free DNA (cf-DNA) Testing market, driven by demand from China, the second largest economy with some signs of stabilising, the Cell-Free DNA (cf-DNA) Testing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cell-Free DNA (cf-DNA) Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cell-Free DNA (cf-DNA) Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cell-Free DNA (cf-DNA) Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cell-Free DNA (cf-DNA) Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cell-Free DNA (cf-DNA) Testing covered in this report include Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited and Natera, etc.
The global Cell-Free DNA (cf-DNA) Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche
Sequenom
Trovagene
Global Cell-Free DNA (cf-DNA) Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cell-Free DNA (cf-DNA) Testing market, Segment by Type:
Donor-derived
Circulating
Cell-free
Global Cell-Free DNA (cf-DNA) Testing market, by Application
Oncology
Gynecology
Transplantation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cell-Free DNA (cf-DNA) Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cell-Free DNA (cf-DNA) Testing
1.1 Cell-Free DNA (cf-DNA) Testing Market Overview
1.1.1 Cell-Free DNA (cf-DNA) Testing Product Scope
1.1.2 Cell-Free DNA (cf-DNA) Testing Market Status and Outlook
1.2 Global Cell-Free DNA (cf-DNA) Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cell-Free DNA (cf-DNA) Testing Market Size by Region (2018-2029)
1.4 Global Cell-Free DNA (cf-DNA) Testing Historic Market Size by Region (2018-2023)
1.5 Global Cell-Free DNA (cf-DNA) Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
1.6.1 North America Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
1.6.2 Europe Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
1.6.4 Latin America Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size (2018-2029)
2 Cell-Free DNA (cf-DNA) Testing Market by Type
2.1 Introduction
2.1.1 Donor-derived
2.1.2 Circulating
2.1.3 Cell-free
2.2 Global Cell-Free DNA (cf-DNA) Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cell-Free DNA (cf-DNA) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Cell-Free DNA (cf-DNA) Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Type (2018-2029)
3 Cell-Free DNA (cf-DNA) Testing Market Overview by Application
3.1 Introduction
3.1.1 Oncology
3.1.2 Gynecology
3.1.3 Transplantation
3.2 Global Cell-Free DNA (cf-DNA) Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cell-Free DNA (cf-DNA) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Cell-Free DNA (cf-DNA) Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cell-Free DNA (cf-DNA) Testing Revenue Breakdown by Application (2018-2029)
4 Cell-Free DNA (cf-DNA) Testing Competition Analysis by Players
4.1 Global Cell-Free DNA (cf-DNA) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cell-Free DNA (cf-DNA) Testing as of 2022)
4.3 Date of Key Players Enter into Cell-Free DNA (cf-DNA) Testing Market
4.4 Global Top Players Cell-Free DNA (cf-DNA) Testing Headquarters and Area Served
4.5 Key Players Cell-Free DNA (cf-DNA) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Cell-Free DNA (cf-DNA) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Agilent Technology
5.1.1 Agilent Technology Profile
5.1.2 Agilent Technology Main Business
5.1.3 Agilent Technology Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.1.4 Agilent Technology Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Agilent Technology Recent Developments
5.2 Allenex
5.2.1 Allenex Profile
5.2.2 Allenex Main Business
5.2.3 Allenex Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.2.4 Allenex Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Allenex Recent Developments
5.3 Biocept
5.3.1 Biocept Profile
5.3.2 Biocept Main Business
5.3.3 Biocept Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.3.4 Biocept Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Biodesix Recent Developments
5.4 Biodesix
5.4.1 Biodesix Profile
5.4.2 Biodesix Main Business
5.4.3 Biodesix Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.4.4 Biodesix Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Biodesix Recent Developments
5.5 CareDx
5.5.1 CareDx Profile
5.5.2 CareDx Main Business
5.5.3 CareDx Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.5.4 CareDx Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 CareDx Recent Developments
5.6 Guardant Health
5.6.1 Guardant Health Profile
5.6.2 Guardant Health Main Business
5.6.3 Guardant Health Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.6.4 Guardant Health Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Guardant Health Recent Developments
5.7 Illumania
5.7.1 Illumania Profile
5.7.2 Illumania Main Business
5.7.3 Illumania Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.7.4 Illumania Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Illumania Recent Developments
5.8 Invited
5.8.1 Invited Profile
5.8.2 Invited Main Business
5.8.3 Invited Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.8.4 Invited Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Invited Recent Developments
5.9 Natera
5.9.1 Natera Profile
5.9.2 Natera Main Business
5.9.3 Natera Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.9.4 Natera Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Natera Recent Developments
5.10 Quest Diagnostics
5.10.1 Quest Diagnostics Profile
5.10.2 Quest Diagnostics Main Business
5.10.3 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.10.4 Quest Diagnostics Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Quest Diagnostics Recent Developments
5.11 Roche
5.11.1 Roche Profile
5.11.2 Roche Main Business
5.11.3 Roche Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.11.4 Roche Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.11.5 Roche Recent Developments
5.12 Sequenom
5.12.1 Sequenom Profile
5.12.2 Sequenom Main Business
5.12.3 Sequenom Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.12.4 Sequenom Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Sequenom Recent Developments
5.13 Trovagene
5.13.1 Trovagene Profile
5.13.2 Trovagene Main Business
5.13.3 Trovagene Cell-Free DNA (cf-DNA) Testing Products, Services and Solutions
5.13.4 Trovagene Cell-Free DNA (cf-DNA) Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Trovagene Recent Developments
6 North America
6.1 North America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cell-Free DNA (cf-DNA) Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cf-DNA) Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cell-Free DNA (cf-DNA) Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cf-DNA) Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cell-Free DNA (cf-DNA) Testing Market Dynamics
11.1 Cell-Free DNA (cf-DNA) Testing Industry Trends
11.2 Cell-Free DNA (cf-DNA) Testing Market Drivers
11.3 Cell-Free DNA (cf-DNA) Testing Market Challenges
11.4 Cell-Free DNA (cf-DNA) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
